anti-Lectin, Galactoside-Binding, Soluble, 9 (LGALS9) Antikörper

LGALS9 was initially thought to represent a pseudogene of galectin 9; however, this transcript has good exon-intron structure and encodes a predicted protein of the same size as and highly similar to galectin 9. Zusätzlich bieten wir Ihnen Lectin, Galactoside-Binding, Soluble, 9 Kits (54) und Lectin, Galactoside-Binding, Soluble, 9 Proteine (39) und viele weitere Produktgruppen zu diesem Protein an.

Alle Antikörper anzeigen Gen GeneID UniProt
LGALS9 16859 O08573
LGALS9 3965 O00182
LGALS9 25476 P97840
Direkt bei antikoerper-online bestellen
  • +49 (0)241 95 163 153
  • +49 (0)241 95 163 155
  • Online bestellen
  • orders@antikoerper-online.de

Top anti-Lectin, Galactoside-Binding, Soluble, 9 Antikörper auf antikoerper-online.de

Showing 10 out of 194 products:

Katalog Nr. Reaktivität Wirt Konjugat Applikation Bilder Menge Anbieter Lieferzeit Preis Details
Rind (Kuh) Kaninchen Unkonjugiert WB WB Suggested Anti-LGALS9 Antibody Titration: 0.2-1 ug/ml ELISA Titer: 1:312500 Positive Control: Human Muscle 100 μL Anmelden zum Anzeigen 6 bis 8 Tage
358,51 €
Details
Human Kaninchen Unkonjugiert EIA, WB Western blot analysis of Galectin-9 Antibody (N-term) in WiDr cell line lysates (35ug/lane). 0.4 mL Anmelden zum Anzeigen 7 bis 9 Tage
407,00 €
Details
Human Maus Unkonjugiert FACS 0.1 mg Anmelden zum Anzeigen 7 bis 9 Tage
440,00 €
Details
Human Maus Unkonjugiert ELISA (Capture), FACS 0.1 mg Anmelden zum Anzeigen 7 bis 9 Tage
440,00 €
Details
Ratte Kaninchen Unkonjugiert WB Observed bind size: 36KD 100 μg Anmelden zum Anzeigen 8 bis 11 Tage
340,48 €
Details
Maus Ziege Unkonjugiert FACS, ICC, WB Detection of Galectin-9 in Mouse Thymocytes by Flow Cytometry. Galectin-9 in Mouse Splenocytes. Galectin-9 was detected in immersion fixed mouse splenocytes using Goat Anti-Mouse Galectin-9 Antigen Affinity-purified Polyclonal Antibody. Specific staining was localized to cytoplasm. 100 μg Anmelden zum Anzeigen 3 bis 4 Tage
355,00 €
Details
Maus Kaninchen Unkonjugiert IF (p), IHC (p), WB Formalin-fixed and paraffin embedded mouse kidney tissue labeled with Anti-Galectin-9 Polyclonal Antibody (ABIN670746), Unconjugated at 1:200, followed by conjugation to the secondary antibody and DAB staining 100 μL Anmelden zum Anzeigen 9 bis 12 Tage
304,36 €
Details
Human Kaninchen Unkonjugiert ELISA, IF, IHC, WB Western Blot (WB) analysis of specific cells using Galectin-9 Polyclonal Antibody. 100 μL Anmelden zum Anzeigen 13 Days
154,33 €
Details
Human Maus Unkonjugiert ELISA, WB LGALS9 polyclonal antibody (A01), Lot # 050928JC01 Western Blot analysis of LGALS9 expression in Jurkat . Western Blot detection against Immunogen (37.33 KDa) . 50 μL Anmelden zum Anzeigen 7 bis 8 Tage
241,60 €
Details
Maus Ratte Alexa Fluor 647 FACS 100 μg Anmelden zum Anzeigen 6 bis 8 Tage
253,65 €
Details

LGALS9 Antikörper nach Reaktivität, Anwendung, Klonalität and Konjugat

Attribute Applikationen Wirt Klonalität Konjugat
Mouse (Murine) , , , ,
, ,
,
, , , , , , , , , , , , , , , , , , ,
Human , , , ,
,
,
, , , , , , , , , , , , , , , , ,
Rat (Rattus) , ,


, , , , , , , , , , , , ,

Am meisten referenzierte anti-Lectin, Galactoside-Binding, Soluble, 9 Antikörper

  1. Mouse (Murine) Monoclonal LGALS9 Primary Antibody für FACS - ABIN2657895 : Dunphy, Barcham, Bischof, Young, Nash, Meeusen: Isolation and characterization of a novel eosinophil-specific galectin released into the lungs in response to allergen challenge. in The Journal of biological chemistry 2002 (PubMed)
    Zeige alle 6 Referenzen für 2657895

  2. Human Monoclonal LGALS9 Primary Antibody für ELISA (Capture), FACS - ABIN1449219 : Yanai, Saito, Kakinuma, Kon, Hirota, Taniguchi-Yanai, Nishijo, Shigematsu, Horiguchi, Kasuya, Sugiyama, Yagami, Murakami, Fukamizu: Renin-dependent cardiovascular functions and renin-independent blood-brain barrier functions revealed by renin-deficient mice. in The Journal of biological chemistry 2000 (PubMed)
    Zeige alle 5 Referenzen für 1449219

  3. Human Polyclonal LGALS9 Primary Antibody für EIA, WB - ABIN952439 : Dardalhon, Anderson, Karman, Apetoh, Chandwaskar, Lee, Cornejo, Nishi, Yamauchi, Quintana, Sobel, Hirashima, Kuchroo: Tim-3/galectin-9 pathway: regulation of Th1 immunity through promotion of CD11b+Ly-6G+ myeloid cells. in Journal of immunology (Baltimore, Md. : 1950) 2010 (PubMed)
    Zeige alle 5 Referenzen für 952439

  4. Human Monoclonal LGALS9 Primary Antibody für FACS - ABIN1449220 : Lipkowitz, Leal-Pinto, Cohen, Abramson: Galectin 9 is the sugar-regulated urate transporter/channel UAT. in Glycoconjugate journal 2004 (PubMed)
    Zeige alle 3 Referenzen für 1449220

  5. Human Polyclonal LGALS9 Primary Antibody für ELISA, WB - ABIN561667 : Bellac, Coimbra, Simon, Imboden, Leib: Gene and protein expression of galectin-3 and galectin-9 in experimental pneumococcal meningitis. in Neurobiology of disease 2007 (PubMed)
    Zeige alle 2 Referenzen für 561667

  6. Cow (Bovine) Polyclonal LGALS9 Primary Antibody für WB - ABIN2785903 : Bi, Earl, Jacobs, Baum: Structural features of galectin-9 and galectin-1 that determine distinct T cell death pathways. in The Journal of biological chemistry 2008 (PubMed)

  7. Mouse (Murine) Polyclonal LGALS9 Primary Antibody für FACS, ICC - ABIN4899254 : Iqbal, Sampaio, Maione, Greco, Niki, Hirashima, Perretti, Cooper: Endogenous galectin-1 and acute inflammation: emerging notion of a galectin-9 pro-resolving effect. in The American journal of pathology 2011 (PubMed)

Weitere Antikörper gegen Lectin, Galactoside-Binding, Soluble, 9 Interaktionspartner

Mouse (Murine) Lectin, Galactoside-Binding, Soluble, 9 (LGALS9) Interaktionspartner

  1. Galectin 9 is a novel dectin 1 (zeige CLEC7A Antikörper) ligand in pancreatic ductal adenocarcinoma. Upon disruption of the dectin 1 (zeige CLEC7A Antikörper)-galectin 9 axis, CD4 (zeige CD4 Antikörper)(+) and CD8 (zeige CD8A Antikörper)(+) T cells, which are dispensable for PDA progression in hosts with an intact signaling axis, become reprogrammed into indispensable mediators of anti-tumor immunity.

  2. The Gal-9/Tim-3 (zeige HAVCR2 Antikörper) signal is important for the regulation of decidua NK cells function, which is beneficial for the maintenance of a normal pregnancy.

  3. These results indicate the possibility that cooperative binding of oligosaccharide and neighboring polypeptide structures of monoclonal IgE to galectin-9 affects the overall affinity and specificity of the IgE-lectin interaction.

  4. galectin-9 functions as a novel alarmin by augmenting the inflammatory response in sepsis development during pulmonary F. novicida infection.

  5. Gal-9 has a role in the maintenance of hepatic homeostasis and preventing liver ischemia-reperfusion injury

  6. Gal-9, a natural TIM-3 (zeige HAVCR2 Antikörper) ligand, was produced primarily by and released from ischemia-reperfusion-stressed hepatocytes, both in vivo and in vitro.

  7. Galectin-9 functions as an astrocyte-microglia communication signal and promotes cytokine production from microglia in a Tim-3 (zeige HAVCR2 Antikörper) independent manner.

  8. galectin-9, in addition to being an effector molecule for regulatory T cells cells, acts synergistically with TGF-beta (zeige TGFB1 Antikörper) to enforce iTreg cell differentiation and maintenance.

  9. Galectin-9 is a suppressor of T and B cells and predicts the immune modulatory potential of mesenchymal stromal cell preparations.

  10. action of agonist anti-4-1BB (zeige TNFRSF9 Antikörper) in suppressing autoimmune and allergic inflammation was completely dependent on Galectin-9 (Gal-9). Gal-9 directly bound to 4-1BB (zeige TNFRSF9 Antikörper), in a site distinct from the binding site of antibodies and the natural ligand of 4-1BB (zeige TNFRSF9 Antikörper)

Human Lectin, Galactoside-Binding, Soluble, 9 (LGALS9) Interaktionspartner

  1. Galectin 9 is a novel dectin 1 (zeige CLEC7A Antikörper) ligand in pancreatic ductal adenocarcinoma. Upon disruption of the dectin 1 (zeige CLEC7A Antikörper)-galectin 9 axis, CD4 (zeige CD4 Antikörper)(+) and CD8 (zeige CD8A Antikörper)(+) T cells, which are dispensable for PDA progression in hosts with an intact signaling axis, become reprogrammed into indispensable mediators of anti-tumor immunity.

  2. X-ray structure of a protease-resistant mutant form of human galectin-9 having two carbohydrate recognition domains with a metal-binding site has been presented.

  3. These findings may indicate that an increase in the Gal-9 level, a novel immune checkpoint molecule, can reflect immune-related adverse effects of various biotherapies.

  4. Our data suggest a role of galectin-9 in regulating HIV transcription and viral production in vivo during therapy

  5. these data suggest that the high Tim-3 (zeige HAVCR2 Antikörper) expression in monocytes could be utilized by tumor-promoting Gal-9 expression on CD4 (zeige CD4 Antikörper)(+) T cells

  6. this study shows that in osteosarcoma patients, Tim3 (zeige HAVCR2 Antikörper) expression did not directly mediate immune suppression, but the interaction between Tim3 (zeige HAVCR2 Antikörper)+ T cells and monocytes, naive CD4 (zeige CD4 Antikörper)+ T cells, and Gal9-expressing CD4 (zeige CD4 Antikörper)+ CD25 (zeige IL2RA Antikörper)+ Tregs could resulting in progressive suppression of Th1 (zeige TH1L Antikörper) responses

  7. The human recombinant galectin-9 has demonstrated anti-cancer activities, including inducing apoptosis in hematological, dermatological and gastrointestinal malignancies. In this review, the molecular characteristics, history and apoptosis-inducing potential of galectin-9 are described. [review]

  8. Results showed that in acute febrile phase, galectin-9 and galectin-3BP were induced in dengue patients compared to healthy controls suggesting that both molecules might be important inflammatory mediators in acute dengue virus infection.

  9. In this review, we summarize the latest knowledge on the structure, receptors, cellular targets, trafficking pathways and functional properties of galectin-9 and discuss how galectin-9-mediated signalling cascades can be exploited in cancers and immunotherapies

  10. this study shows that the levels of expression of Gal-9 on CD4 (zeige CD4 Antikörper)+ T cells, CD8 (zeige CD8A Antikörper)+ T cells, CD56 (zeige NCAM1 Antikörper)+ T cells and in serum in patients with systemic lupus erythematosus are significantly higher than those of healthy controls

Cow (Bovine) Lectin, Galactoside-Binding, Soluble, 9 (LGALS9) Interaktionspartner

  1. The Tim-3 (zeige HAVCR2 Antikörper)/Gal-9 pathway might link disease progression with T cell exhaustion during bovine leukemia virus infection.

  2. The relative abundance of PIBF (zeige PIBF1 Antikörper), LGALS1 (zeige LGALS1 Antikörper), LGALS3 (zeige LGALS2 Antikörper), LGALS3BP (zeige LGALS3BP Antikörper), and LGALS9 mRNA would display a differential expression pattern in the endometrium.

Lectin, Galactoside-Binding, Soluble, 9 (LGALS9) Antigen-Profil

Protein Überblick

The galectins are a family of beta-galactoside-binding proteins implicated in modulating cell-cell and cell-matrix interactions. The protein encoded by this gene is an S-type lectin. It is overexpressed in Hodgkin's disease tissue and might participate in the interaction between the H&RS cells with their surrounding cells and might thus play a role in the pathogenesis of this disease and/or its associated immunodeficiency. Multiple alternatively spliced transcript variants have been found for this gene.

Genbezeichner und Symbole assoziert mit LGALS9

  • lectin, galactoside-binding, soluble, 9 (lgals9) Antikörper
  • zgc:92326 (zgc:92326) Antikörper
  • lectin, galactoside-binding, soluble, 9 (LGALS9) Antikörper
  • galectin-9 (LOC100350347) Antikörper
  • galectin-9-like (LOC100728329) Antikörper
  • lectin, galactose binding, soluble 9 (Lgals9) Antikörper
  • lectin, galactoside-binding, soluble, 9 (Lgals9) Antikörper
  • AA407335 Antikörper
  • AI194909 Antikörper
  • AI265545 Antikörper
  • ecalectin Antikörper
  • gal-9 Antikörper
  • galectin-9 Antikörper
  • HUAT Antikörper
  • Lgals5 Antikörper
  • LGALS9 Antikörper
  • LGALS9A Antikörper
  • LGALS35 Antikörper
  • UAT Antikörper
  • UATP.I Antikörper
  • wu:fd20c09 Antikörper
  • zgc:111833 Antikörper

Bezeichner auf Proteinebene für LGALS9

lectin, galactoside-binding, soluble, 9 , galactoside-binding soluble lectin 9 , galectin 9 , lectin, galactoside-binding, soluble, 9 (galectin 9) , galectin-9 , lectin, galactose binding, soluble 5 , ecalectin , gal-9 , tumor antigen HOM-HD-21 , urate transporter/channel protein , 36 kDa beta-galactoside-binding lectin , Lectin galactose binding soluble 9 (Galectin-9) , Lectin, galactose binding, soluble 9 (Galectin-9) , UAT , urate transporter/channel , urate transporter , urate transporter/channel protein, isoform (UATp,i)

GENE ID SPEZIES
733366 Xenopus laevis
100145704 Xenopus (Silurana) tropicalis
327284 Danio rerio
454519 Pan troglodytes
100350347 Oryctolagus cuniculus
100728329 Cavia porcellus
16859 Mus musculus
3965 Homo sapiens
25476 Rattus norvegicus
442861 Canis lupus familiaris
396972 Sus scrofa
510813 Bos taurus
Ausgewählte Anbieter für anti-Lectin, Galactoside-Binding, Soluble, 9 (LGALS9) Antikörper
Haben Sie etwas anderes gesucht?